Adult Vaccines Market Drivers, Trends, and Forecasts by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Adult Vaccines Market covers analysis By Type (Preventive Vaccine, Therapeutic Vaccine); Disease (Influenza, Meningococcal, Zoster Shingles, Pneumococcal,Diphtheria, Tetanus, Pertussis (DTP), Hepatitis, Measles, Mumps, Rubella and Varicella (MMRV)); Technology (Non-Live Attenuated Vaccines, Inactivated Viral/Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Aug 2025
  • Report Code : TIPRE00007244
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150

The Adult Vaccines Market is expected to register a CAGR of 11.6% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The Adult Vaccines Market report covers analysis by Type (Preventive Vaccine, Therapeutic Vaccine); Disease (Influenza, Meningococcal, Zoster Shingles, Pneumococcal,Diphtheria, Tetanus, Pertussis (DTP), Hepatitis, Measles, Mumps, Rubella and Varicella (MMRV)); Technology (Non-Live Attenuated Vaccines, Inactivated Viral/Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.

Purpose of the Report

The report Adult Vaccines Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Adult Vaccines Market Segmentation

Type

  • Preventive Vaccine
  • Therapeutic Vaccine

Disease

  • Influenza
  • Meningococcal
  • Zoster Shingles
  • Pneumococcal
  • Diphtheria
  • Tetanus
  • Pertussis
  • Hepatitis
  • Measles
  • Mumps
  • Rubella and Varicella

Technology

  • Non-Live Attenuated Vaccines
  • Inactivated Viral/Bacterial Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Conjugate Vaccines

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Adult Vaccines Market: Strategic Insights

adult-vaccines-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Adult Vaccines Market Growth Drivers

  • Growing Prevalence of Chronic Diseases: The rising cases of chronic diseases, such as diabetes, cardiovascular diseases, and respiratory disorders, in adults have also increased the need for adult vaccines. Adult vaccines prevent infections that can lead to complications with chronic diseases, thereby minimizing the potential serious health outcomes. This is pushing healthcare providers to recommend vaccines as part of standard care for adults, especially those with chronic diseases.
  • Awareness towards preventive healthcare: Increased health consciousness in adults is boosting preventive healthcare measures. The vaccination market is growing through public awareness campaigns and education on adult vaccination to avoid severe illnesses, hospitalizations, and long-term health complications. Public health agencies are also adopting this vaccination for adults, which would drive market growth.
  • Aging Global Population: A rapidly aging global population is the key driver for the adult vaccines market. Older adults are more prone to infections due to weakened immune systems, making vaccination an important preventive measure. The flu, pneumonia, and shingles vaccines are crucial in the elderly, thus boosting the demand for such vaccines. The rising number of the elderly population has fueled the demand for adult vaccines and opened avenues for healthcare providers to offer focused vaccination programs.

Adult Vaccines Market Future Trends

  • Increased Focus on Combination Vaccines: The world is increasingly looking at combination vaccines that protect the human body against a variety of diseases with just one shot. Besides the added advantage of convenience, this vaccine increases vaccination rates since people are spared from multiple injections. Adult combination vaccines, for instance, include protection against influenza, pneumonia, and other infections.
  • Increased Demand for Travel Vaccines: The world is becoming smaller, and many people are taking to traveling from one place to another. There are increasing demands on vaccines that cover diseases common to certain regions like yellow fever, typhoid, and hepatitis. Travel vaccination for adults has become part of the preparatory health visit. The number of international trips taken is what fuels the demand for traveler-specific vaccines.
  • Growing role of pharmacies in vaccine administration: One of the key trends where pharmacies play a critical role in the administration of vaccines to adults, particularly in developed countries. Since many pharmacies are collaborating with various healthcare providers for vaccination services, adults now find it relatively easier to access vaccines. As such, this trend expands adult vaccination programs and enhances accessibility to vaccines, thereby contributing to the growth of the market as a whole.

Adult Vaccines Market Opportunities

  • Cancer Vaccines: Cancer vaccines, such as those against human papillomavirus (HPV) and other cancers, are an exciting opportunity in the adult vaccines market. As cancer prevention becomes a more prominent focus in healthcare, the demand for vaccines that help prevent cancer-causing infections or directly target cancer cells is expected to rise. Investment in this area could lead to groundbreaking treatments and capture a significant share of the adult vaccine market.
  • Personalized and Targeted Vaccines: A promising area for adult vaccines would be personalized and targeted vaccines that will be designed from individual genetic profiles. Personalized vaccines are specifically tailored to the individual needs and risks of adult patients, which could increase effectiveness and lead to better patient outcomes. Advances in genomics and biotechnology might create a niche for these special vaccines, offering adult immunization opportunities.
  • Increasing Emphasis on Global Health Initiatives: International health organizations, such as the World Health Organization (WHO), are increasingly focusing on adult vaccination as part of their global health initiatives. Governments, international organizations, and private companies can collaborate to expand vaccination programs across the globe. The development of adult vaccination initiatives in underdeveloped countries would significantly increase market growth, especially in low- and middle-income regions.

Adult Vaccines Market Regional Insights

The regional trends and factors influencing the Adult Vaccines Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Adult Vaccines Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

adult-vaccines-market-global-geography
  • Get the Regional Specific Data for Adult Vaccines Market

Adult Vaccines Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 11.6%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Type
  • Preventive Vaccine
  • Therapeutic Vaccine
By Disease
  • Influenza
  • Meningococcal
  • Zoster Shingles
  • Pneumococcal
  • Diphtheria
  • Tetanus
  • Pertussis
  • Hepatitis
  • Measles
  • Mumps
  • Rubella and Varicella
By Technology
  • Non-Live Attenuated Vaccines
  • Inactivated Viral/Bacterial Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Conjugate Vaccines
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • AstraZeneca
  • Bharat Biotech
  • Dynavax Technologies Corporation
  • GlaxoSmithKline
  • Johnson and Johnson
  • Merck and Co
  • Novartis
  • Pfizer
  • Sanofi Pasteur

  • Adult Vaccines Market Players Density: Understanding Its Impact on Business Dynamics

    The Adult Vaccines Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Adult Vaccines Market are:

    1. AstraZeneca
    2. Bharat Biotech
    3. Dynavax Technologies Corporation
    4. GlaxoSmithKline
    5. Johnson and Johnson
    6. Merck and Co

    Disclaimer: The companies listed above are not ranked in any particular order.


    adult-vaccines-market-cagr

    • Get the Adult Vaccines Market top key players overview

    Key Selling Points

    • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Adult Vaccines Market, providing a holistic landscape.
    • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
    • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
    • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

    The research report on the Adult Vaccines Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


    Frequently Asked Questions

    What are the major driving factors impacting the Adult Vaccines Market?

    The major factors driving the Adult Vaccines Market are Growing Prevalence of Chronic Diseases, Awareness towards preventive healthcare, and Aging Global Population

    What are the future trends of the Adult Vaccines Market?

    The key future trends of the market are Increased Focus on Combination Vaccines, Increased Demand for Travel Vaccines, and Growing role of pharmacies in vaccine administration

    Which are the leading players operating in the Adult Vaccines Market?

    The leading players operating in the Adult Vaccines Market include

    What are the deliverable formats of Adult Vaccines Market report?

    The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

    What are the options available for the customization of this report?

    Some of the customization options available based on the request are an additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    The List of Companies

    1.AstraZeneca
    2.Bharat Biotech
    3.Dynavax Technologies Corporation
    4.GlaxoSmithKline
    5.Johnson and Johnson
    6.Merck and Co
    7.Novartis
    8.Pfizer
    9.Sanofi Pasteur
    10.Serum Institute of India
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo